• Agenda
    • Get Involved
    • Programs
    • In-Person Breakouts
    • Short Courses
    • Plenary Keynotes
    • Speaker Biographies
    • Training Seminars
    • Attendees
    • Search the Agenda
    • Networking
    • Archives
  • Sponsor/Exhibitor
    • Attendee Demographics + Event Features
    • Sponsorship Opportunities
    • Current Sponsors
    • Current Exhibitors - Floorplan
    • Re-sign Floorplan
    • Exhibit Services Schedule
    • Exhibitor Prospectus
    • Lead Generation Opportunities
    • FAQs
    • Sponsor & Exhibitor Portal
    • Best of Show Awards
  • Media
    • Media Partners
    • Downloads
    • Media Gallery
  • Travel
  • Posters
    • Poster Information
    • Poster Titles
  • Register
    • Individual Pricing
    • Group Pricing
    • On Demand Pricing
Discovery on Target 2025

2024 Media Partners

Official Publications

  • Bio-IT World
  • Diagnostic World News

Sponsoring Publications

  • American_Pharmaceutical_Review
    •  
  •  de-gruyter
  • Pharmaceutical_Outsourcing
  • PharmaVoice

Lead Media Partners

  • Biocompare
  • labcompare

Media Partners

  • BioPharma Asia Logo Image
  • Dr GPCR Logo

Web Sponsors

  • Big3Bio
  • Bioseeker-1st-Oncology
  • Genetic-Engineering-Biotech-News
    •  
  • pharmaceutics

 


Outlook YouTube LinkedIn Twitter
#BostonDOT25
Submit a Speaker Proposal
Stay up to Date on our Program
Stay up to Date on our Program
2024 Programs
View Event Testimonial Highlights
Submit a Poster
View All Sponsors

Conference Programs

September 22

Covalent Chemistries and Induced Proximity Strategies for Targeting Kinases Immune Modulation Strategies Non-Animal Alternative Models for Preclinical & IND Studies NEW

September 23-24

Degraders and Molecular Glues – Part 1 Emerging Drug Targets: Identification & Validation NEW Small Molecules for Cancer Targets Antibodies Against Membrane Protein Targets Small Molecules Targeting DNA & RNA AI/ML-Enabled Drug Discovery – Part 1 MASH & Obesity NEW

September 24-25

Degraders and Molecular Glues – Part 2 Lead Generation Strategies Cancer Antibodies GPCR-Based Drug Discovery Targeting Transcription Factors AI/ML-Enabled Drug Discovery – Part 2 Achieving Target Exposure through ADME and PK
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers

Request Information

Privacy Policy